ACE-1332

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameACE-1332
Drug Alias NameACE-1332RAP-1332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming growth factor beta 1 inhibitors
TargetsTransforming growth factor beta 1
Therapy Area/IndicationsFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcceleron Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAcceleron Pharma Inc
Active IndicationsN/A
Inactive IndicationsFibrosis

Other Information

ATC CodeN/A
Related LinksN/A